HUTCHMED (China) Limited

As of December 31, 2025, HUTCHMED (China) Limited Sponsored ADR carries a market capitalization of 2.34B, placing it among publicly traded companies globally. Its enterprise value stands at 1.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

HUTCHMED (China) Limited Sponsored ADR's next confirmed earnings release is scheduled for March 4, 2027.

As of December 31, 2025, HUTCHMED (China) Limited Sponsored ADR has 176.21M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, HUTCHMED (China) Limited Sponsored ADR maintains a current ratio of 4.96, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, HUTCHMED (China) Limited Sponsored ADR's stock has declined approximately 5.16% over the past 52 weeks. The 50-day moving average sits at 13.51, while the 200-day moving average is 13.27.

As of December 31, 2025, HUTCHMED (China) Limited Sponsored ADR holds 1.37B in cash and equivalents against 97.89M in total debt, resulting in a net debt position of 21.83M. Total book value stands at 1.24B, with working capital of 1.25B providing operational flexibility.